Regeneron (REGN) Says EYLEA Clinically Equivalent to Lucentis Following VIEW 1, 2 Phase 3s

Go back to Regeneron (REGN) Says EYLEA Clinically Equivalent to Lucentis Following VIEW 1, 2 Phase 3s
Regeneron (NASDAQ: REGN) Delayed: 690.88 --0 (-0%)
Previous Close $690.88    52 Week High $592.36 
Open $690.88    52 Week Low $325.35 
Day High $690.88    P/E 181.33 
Day Low $690.88    EPS $3.81 
Volume 40